#Skincancer

A large wave of new evidence is adding to the chorus of dermatologists recommending nicotinamide, a form of vitamin B3, as a daily supplement to help prevent new skin cancers in people at high risk. In a growing body of research, this common dietary ingredient—already familiar to many as a multivitamin staple—appears to reduce the number of new skin cancer cases when taken regularly over time. The findings come amid a broader push in public health to combine everyday wellness habits with proven medical prevention strategies, a message that resonates deeply in sun-soaked Thailand where outdoor work and cultural gatherings intensify UV exposure.

A landmark study from a leading health institute shows that beta HPV, a common skin virus, can directly drive skin cancer in individuals with severely weakened immune systems. Published in a top medical journal, the findings reshape our understanding of how some skin cancers develop and underscore the need for vigilant monitoring among at-risk groups. For Thai readers, the research aligns with rising non-melanoma skin cancer rates and increasing use of immunosuppressive therapies in the region.

A groundbreaking study from the National Institutes of Health in the United States has confirmed for the first time that a form of human papillomavirus (HPV) commonly found on the skin—beta HPV—can directly cause skin cancer in individuals with severely weakened immune systems. The findings, published recently in the New England Journal of Medicine, have significant implications for how some skin cancers may develop and reinforce the importance of vigilant health monitoring in immunocompromised populations. For Thai readers, this development is particularly relevant given the rising rates of both non-melanoma skin cancer and immunosuppressive conditions in the region.

A recent international meta-analysis has shaken perceptions about wine and health, revealing that white wine—long believed by some to be a “lighter,” lower-risk alcohol choice—may increase the risk of skin cancer, particularly for women. While both red and white wine are forms of alcohol known to elevate cancer risk overall, white wine has now been shown to carry specific risks that have not been widely recognized, according to a sweeping 2025 review by scientists at Brown University and corroborated by several other reputable research institutions (Brown University report, MDPI meta-analysis, News-Medical).

A comprehensive meta-analysis released in 2025 challenges the idea that white wine is a safer, lighter alcohol choice. Researchers from Brown University, supported by other respected institutions, found that white wine is associated with a higher risk of skin cancer, especially among women. The study combined data from 42 studies with about 96,000 participants and showed a 22% increase in skin cancer risk for white wine drinkers, while red wine did not show a significant protective effect. Among women, white wine was linked to a 26% higher overall cancer risk. This research marks the most thorough examination to date of how wine type may influence cancer risk, undermining the notion that white wine is benign.

The integration of artificial intelligence (AI) into skin cancer detection is gaining momentum, heralding a potentially transformative shift in medical diagnostics. However, experts emphasize that while AI technologies are advancing, human expertise remains irreplaceable. Ivy Lee, a dermatologist in Los Angeles and chair of the Augmented Intelligence Committee at the American Academy of Dermatology, reflects this sentiment, noting that the industry’s maturity moves beyond previous media hype towards practical applications of AI in healthcare.

AI is accelerating skin cancer detection, offering new ways to improve access to care. Yet experts warn that human clinicians remain essential. A leading dermatologist in Los Angeles and chair of the Augmented Intelligence Committee at the American Academy of Dermatology notes that AI’s maturity is shifting from hype to practical medical use, while doctors oversee care and patient interactions that machines cannot replace.

A landmark Nature study from 2017 showed AI models analyzing more than 129,000 clinical images could outperform several dermatologists in diagnosing skin cancer. Critics, however, remind us that real diagnosis blends image analysis with patient history, physical examination, and interpersonal care. As a senior clinician at a major U.S. cancer center emphasizes, photos alone cannot capture the full clinical picture.